Please login to the form below

Not currently logged in
Email:
Password:

FDA conforms to Plan B ruling

The FDA has announced it will not appeal against a federal court's ruling to allow the morning-after pill, Plan B, to be marketed in the US to girls aged 17 and over

The US Food and Drug Administration (FDA) has announced it will not appeal against a federal court's ruling to allow the morning-after pill, Plan B, to be marketed in the US to girls aged 17 and over.

In March 2009, Judge Edward Korman ruled that the FDA decision had been made on political grounds and was not consistent with the scientific findings made in 2005 by the Centre for Drug Evaluation and Research. 

The FDA has since notified Duramed Research, the manufacturers of the emergency contraceptive, that upon submission and approval of an appropriate application, Plan B can be marketed for use by girls over 17 years old without a prescription.

Duramed Research is a subsidiary of Teva Pharmaceuticals.

23rd April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics